End-stage Renal Disease [clinicaltrials_resource:b8c5fd7f6532059f83b7c76ba1e45530]
clinicaltrials:NCT00205556clinicaltrials:NCT00218790The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers [clinicaltrials:NCT00234156]clinicaltrials:NCT00237718Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY) [clinicaltrials:NCT00295191]Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation [clinicaltrials:NCT00307463]Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation [clinicaltrials:NCT00428012]clinicaltrials:NCT00556933Arterial pH and N-balances in APD [clinicaltrials:NCT00586131]clinicaltrials:NCT00648167Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease [clinicaltrials:NCT00692562]Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease [clinicaltrials:NCT00718848]clinicaltrials:NCT00745225A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation [clinicaltrials:NCT00785265]clinicaltrials:NCT00825318clinicaltrials:NCT00882557Does Moderate Physical Activity in Hemodialysis Patients Reduce Inflammation? [clinicaltrials:NCT00893165]clinicaltrials:NCT00912782clinicaltrials:NCT00967993Acupuncture for Pain Management of Hemodialysis Patients [clinicaltrials:NCT01102816]MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5 [clinicaltrials:NCT01121237]clinicaltrials:NCT01175798Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis [clinicaltrials:NCT01207297]clinicaltrials:NCT01254214Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates [clinicaltrials:NCT01261910]Pentoxifylline and Systemic Inflammation in Hemodialysis Patients [clinicaltrials:NCT01269827]Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients [clinicaltrials:NCT01271478]Mechanisms and Treatment of Intradialytic Hypertension - Sodium [clinicaltrials:NCT01371890]clinicaltrials:NCT01394341clinicaltrials:NCT01435174Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis [clinicaltrials:NCT01445366]Fosrenol and Phosphorus Balance - Lanthanum Carbonate [clinicaltrials:NCT01581996]clinicaltrials:NCT01601873Islet Transplant for Type 1 or Surgical Diabetes [clinicaltrials:NCT01606475]The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy [clinicaltrials:NCT01612182]Functional Reserve Estimation of Donor Kidney [clinicaltrials:NCT01689272]clinicaltrials:NCT01723111Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD [clinicaltrials:NCT01744418]Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration [clinicaltrials:NCT01778283]Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease [clinicaltrials:NCT01840956]
condition [clinicaltrials_vocabulary:condition]
End-stage Renal Disease [clinicaltrials_resource:b8c5fd7f6532059f83b7c76ba1e45530]
Bio2RDF identifier
b8c5fd7f6532059f83b7c76ba1e45530
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b8c5fd7f6532059f83b7c76ba1e45530
identifier
clinicaltrials_resource:b8c5fd7f6532059f83b7c76ba1e45530
title
End-stage Renal Disease
@en
label
End-stage Renal Disease [clinicaltrials_resource:b8c5fd7f6532059f83b7c76ba1e45530]
@en